Hostname: page-component-848d4c4894-jbqgn Total loading time: 0 Render date: 2024-06-23T13:06:10.407Z Has data issue: false hasContentIssue false

An epidemiological study of paediatric pulmonary hypertension in Turkey

Published online by Cambridge University Press:  19 June 2015

Ayhan Pektas*
Affiliation:
Department of Pediatric Cardiology, Afyon Kocatepe University Medical School Hospital, Afyonkarahisar, Turkey
Bilgehan M. Pektas
Affiliation:
Department of Pharmacology, Afyon Kocatepe University Medical School, Afyonkarahisar, Turkey
Serdar Kula
Affiliation:
Department of Pediatric Cardiology, Gazi University Medical School Hospital, Ankara, Turkey
*
Correspondence to: A. Pektas, MD, Selcuklu Mah., Adnan Kahveci Cad. No: 16/2 03128, Afyonkarahisar 03200, Turkey. Tel: +90 272 246 3333; Fax: +90 272 246 3322; E-mail: drayhanpektas@hotmail.com

Abstract

Objective

The present study aims to evaluate the epidemiological characteristics of paediatric pulmonary hypertension within the entire Turkish population over a period of 5 years using the registry of the National Health Insurance System.

Methods

All individuals aged <18 years who were admitted to a Turkish hospital for the first time between 2009 and 2013 with a discharge diagnosis of idiopathic pulmonary hypertension and secondary pulmonary hypertension were identified.

Results

The overall annual incidence of idiopathic pulmonary hypertension during childhood was 11.7 cases/million, whereas the overall annual incidence of secondary pulmonary hypertension during childhood was 9.5 cases/million. There was a gradual and significant increase in the annual incidence of idiopathic pulmonary hypertension and that of secondary pulmonary hypertension during the 5-year study period (p=0.001 for both). In the years 2012 and 2013, idiopathic pulmonary hypertension was significantly more frequent in children aged <2 years when compared with children aged above 2 years (p=0.002 for both). The male to female ratio was 1.2:1 for idiopathic pulmonary hypertension, whereas the female to male ratio was 1.1:1 for secondary pulmonary hypertension during childhood.

Conclusion

The incidence of paediatric pulmonary hypertension in Turkey is higher than those reported for the Western populations. Moreover, no female dominance could be observed. These discrepancies may be attributed to the differences in the study design, study cohort, timing of the study, and the definitions adopted for pulmonary hypertension classification.

Type
Original Articles
Copyright
© Cambridge University Press 2015 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Ivy, DD, Abman, SH, Barst, RJ, et al. Pediatric pulmonary hypertension. J Am Coll Cardiol 2013; 62 (25 Suppl): D117D126.CrossRefGoogle ScholarPubMed
2. Wu, DC, Zhang, HD, Jing, ZC. Pediatric pulmonary arterial hypertension. Curr Hypertens Rep 2013; 15: 606613.Google Scholar
3. Simonneau, G, Gatzoulis, MA, Adatia, I, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2013; 62 (25 Suppl): D34D41.CrossRefGoogle ScholarPubMed
4. Berger, RM, Beghetti, M, Humpl, T, et al. Clinical features of paediatric pulmonary hypertension: a registry study. Lancet 2012; 379: 537546.Google Scholar
5. Barst, RJ, McGoon, MD, Elliott, CG, Foreman, AJ, Miller, DP, Ivy, DD. Survival in childhood pulmonary arterial hypertension: insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management. Circulation 2012; 125: 113122.Google Scholar
6. Moledina, S, Hislop, AA, Foster, H, Schulze-Neick, I, Haworth, SG. Childhood idiopathic pulmonary arterial hypertension: a national cohort study. Heart 2010; 96: 14011406.CrossRefGoogle ScholarPubMed
7. van Loon, RL, Roofthooft, MT, Hillege, HL, et al. Pediatric pulmonary hypertension in the Netherlands: epidemiology and characterization during the period 1991 to 2005. Circulation 2011; 124: 17551764.Google Scholar
8. Fasnacht, MS, Tolsa, JF, Beghetti, M, Swiss Society for Pulmonary Arterial Hypertension. The Swiss registry for pulmonary arterial hypertension: the paediatric experience. Swiss Med Wkly 2007; 137: 510513.Google Scholar
9. Fraisse, A, Jais, X, Schleich, JM, et al. Characteristics and prospective 2-year follow-up of children with pulmonary arterial hypertension in France. Arch Cardiovasc Dis 2010; 103: 6674.Google Scholar
10. McGoon, MD, Benza, RL, Escribano-Subias, P, et al. Pulmonary arterial hypertension: epidemiology and registries. J Am Coll Cardiol 2013; 62 (25 Suppl): D51D59.CrossRefGoogle ScholarPubMed
11. Cerro Marín, MJ, Sabaté Rotés, A, Rodriguez Ogando, A, et al. Assessing pulmonary hypertensive vascular disease in childhood. Data from the Spanish registry. Am J Respir Crit Care Med 2014; 190: 14211429.Google Scholar
12. Sahin, AA. The key to health services in Turkey: new perspectives on leadership and hospital management. World Hosp Health Serv 2014; 50: 78.Google Scholar
13. World Health Organization. Manual of the International Statistical Classification of Diseases, Injuries and Causes of Death, 10th revision. World Health Organization, Geneva, 1996.Google Scholar
14. Atun, R, Aydın, S, Aran, M, Gürol, I, Chakraborty, S, Akdag, R. Health-care reform in Turkey: far from perfect – authors’ reply. Lancet 2014; 383: e1.Google Scholar
15. Krishnan, U, Rosenzweig, EB. Pulmonary arterial hypertension associated with congenital heart disease. Clin Chest Med 2013; 34: 707717.CrossRefGoogle ScholarPubMed
16. Haworth, SG, Hislop, AA. Treatment and survival in children with pulmonary arterial hypertension: the UK Pulmonary Hypertension Service for Children 2001–2006. Heart 2009; 95: 312317.Google Scholar
17. Takatsuki, S, Soep, JB, Calderbank, M, Ivy, DD. Connective tissue disease presenting with signs and symptoms of pulmonary hypertension in children. Pediatr Cardiol 2011; 32: 828833.Google Scholar
18. McLaughlin, VV, Presberg, KW, Doyle, RL, et al. Prognosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 2004; 126 (Suppl 1): 78S92S.Google Scholar
19. Galie, N, Seeger, W, Naeije, R, Simmoneau, G, Rubin, LJ. Comparative analysis of clinical trials and evidence-based treatment algorithm in pulmonary arterial hypertension. J Am Coll Cardiol 2004; 43 (Suppl 12): S76S88.Google Scholar
20. Wu, DC, Zhang, HD, Jing, ZC. Pediatric pulmonary arterial hypertension. Curr Hypertens Rep 2013; 15: 606613.Google Scholar